Keywords: GlaxoSmithKline, First-quarter 2012 financial results
GlaxoSmithKline net profits fall, but firm upbeat as sales grow
Article | 26 April 2012
Shares of UK pharma giant GlaxoSmithKline (LSE: GSK) fell 3% to £14.14 yesterday, after the company reported first-quarter 2012 financial results, showing ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
